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a  b  s  t  r  a  c  t
The  leaves  of  Pycnanthus  angolensis  (Welw.)  Warb.,  Myristicaceae,  are  used  as  memory  enhancer  and
anti-ageing  in  Nigerian  ethnomedicine.  This  study  aimed  at evaluating  the  cholinesterase  inhibitory
property  as  well  as isolates  the  bioactive  compounds  from  the  plant.  The  acetylcholinesterase  and  butyryl-
cholinesterase  inhibitory  potentials  of  extracts,  fractions,  and  isolated  compounds  were  evaluated  by
colorimetric  and TLC  bioautographic  assay  techniques.  The extract  inhibited  both  enzymes  with  activ-
ity  increasing  with  puriﬁcation,  ethyl  acetate  fraction  being  most  active  fraction  at  65.66 ±  1.06%  and
49.38  ± 1.66%  against  acetylcholinesterase  and  butyrylcholinesterase,  respectively  while  the  supernatant
had  77.44  ± 1.18  inhibition  against  acetylcholinesterase.  Two  new  bioactive  compounds,  (2E, 18E)-
3,7,11,15,18-pentamethylhenicosa-2,18-dien-1-ol  (named  eluptol)  and  [12-(4-hydroxy-3-methyl-oxo-
cyclopenta-1,3-dien-1yl)-11-methyl-dodecyl](E)-3-(3,4-dimethylphenyl)prop-2-enoate  (named  omi-
foate A)  were  isolated  from  the  plant  with  IC50 of 22.26  g/ml  (AChE),  34.61  g/ml  (BuChE)  and  6.51  g/ml
(AChE),  9.07  g/ml (BuChE)  respectively.  The  results  showed  that the  plant  has  cholinesterase  inhibitory
activity  which  might  be  responsible  for its  memory  enhancing  action,  thus  justifying  its inclusion  in
traditional  memory  enhancing  preparations
rasil
he  CC© 2016  Sociedade  B
access  article  under  t
ntroduction
Alzheimer’s disease (AD) is a neurodegenerative disorder affect-
ng several people and is yet incurable (Prinz et al., 2013). This
akes an urgent need for the development of highly effective
edications and therapies very imperative, even though the mul-
ifactorial nature of the disease, involving several unbalanced
etwork of receptors and enzymes has made both diagnosis and
reatment very difﬁcult (Ballard et al., 2011).
Nevertheless, current management strategies for AD are based
n N-methyl-d-aspartate receptor (NMDA) antagonist meman-
ine and acetylcholineaterase inhibitors (AChEI) such as donopesil,
ivastigmine and galanthamine (Prinz et al., 2013). Although
emantine can slow down the rate of neurodegeneration in AD,
t does not provide a cure for the disease (Massoud and Gauthier,
010). Cholinesterase inhibitors on the other hand improve
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E-mail: taiwo.eluﬁoye@ui.edu.ng (T.O. Eluﬁoye).
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reativecommons.org/licenses/by-nc-nd/4.0/).eira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
cholinergic activity in the brain of AD patient and still remain good
treatment option.
It is a known fact that the use of alternative medicine is on
the increase all over the world with the most increase involving
the use of herbal medicine, folk medicine, homoeopathy and mas-
sage (Eisenberg et al., 1998; Ernst, 2000). There may be several
reasons for this increase but three basic theories: patient dissatis-
faction with conventional treatment as a result of ineffectiveness,
adverse effects and cost, patients need for more personal control
over their health and better compatibility with patients’ values,
spiritual/religious belief and world view, have been proposed to
provide some explanations (Astin, 1998). It has also been suggested
that with time, this continuing demand for alternative therapies
will have great effect on health care delivery (Kessler et al., 2001).
Little wonder why great research efforts are being concentrated in
this area with particular emphasis on herbal medicine and medic-
inal plants.
Medicinal plants have also been good sources of clinical drugs
in general for many years (Li and Vederas, 2009; Silverman and
Holladay, 2014). Many drugs in clinical practice today are either
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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irectly from medicinal plants or have their basic template from
ompounds derived from plants (Lazarus, 2008) and plants have
lso contributed signiﬁcantly in providing drugs for the treatment
f CNS disorders. These include tropane alkaloids from Erythrox-
lun coca, opium alkaloids from Papava somniferum, and the
holinesterase inhibitor physostigmine from Physostigma veneno-
um (Burger, 2003) as well as galantamine from Narcissus species
Berkov et al., 2009). Several other cholinesterase inhibitors in par-
icular have been isolated from medicinal plants (Mukherjee et al.,
007; Ahmed et al., 2013).
Pycnanthus angolensis (Welw.) Warb., Myristicaceae, commonly
alled African nutmeg, is an evergreen tree about 25–35 m high
nd 60–100 cm in diameter (Orwa et al., 2009). The use of different
arts of the plant in folklore is well documented (Achel et al., 2012).
he leaf juice has been used for oral thrush in children (Abbiw,
990) while a decoction of the leaves has been found useful in
lcer, wound healing, and haemorrhoids (Agyare et al., 2009). The
tem has also been reported useful in jaundice, coated tongue and
uberculosis (Fort et al., 2000; Tsaassi et al., 2010; Ashidi et al.,
010). Several bioactive compounds, some of which are potential
rug leads have been isolated from the plant. The cytotoxic effect
f ﬂavonoids isolated from the plant has been reported (Mansoor
t al., 2011). Analgesic and anti-inﬂammatory fatty acids have
lso been reported in the plant (Brill et al., 2004). Other reported
ctivities include antioxidant (Oladimeji and Akpan, 2015), anti-
elminthic (Onocha and Otunla, 2010), antimalarial (Ancolio et al.,
002) and cholesterol lowering (Leonard, 2004), antinociceptive
nd antiulcer (Soﬁdiya and Awolesi, 2015).
We  have also previously reported the cholinesterase, both acetyl
nd butyryl, inhibitory activity of crude extracts of this plant
Eluﬁoye et al., 2010). In this study, we isolated and characterized
he cholinesterase inhibitory constituent from the plant.
aterials and methods
hemicals
The chemicals used include electric eel acetylcholinesterase
EC 3.1.1.7, type VI-s) and Horse butyxylcholinesterase (EC
.1.1.8) which were products of Fluka Co., Germany. Acetylcholine
odide (ATCHI), buthrylcholine chloride (BuCHCl), 5,5-dithio-bis-
itrobenzene acid (DTNB), and physiostigmine (eserine) salicylate
ere from Sigma Co., UK. Reagents for buffer include disodium
ydrogen orthophosphate dihydrate (Na2HPO4·2H2O) and sodium
ihydrogen phosphate (NaH2PO4·12H2O), both of which were of
nalytical grade. Also used were silica gel for column (ASTM), and
re-coated TLC plates, G60PF254 (Merck).
lant material collection and authentication
The plant Pycnanthus angolensis (Welw.) Warb., Myristicaceae,
as identiﬁed by Mr.  Oladele of the Department of Pharmacognosy,
aculty of Pharmacy, and authenticated by Dr. H. Illoh of the Botany
epartment, Obafemi Awolowo University, Ile-Ife with herbarium
umber IFE 13039. The leaves were collected form Road 7, O.A.U
ampus in August 2005.
reparation of extract and fractions
The powdered leaves were macerated with 80% methanol for
2 h and extract was concentrated in vacuo to dryness at 40 ◦C. The
ethanolic extract was partitioned into hexane, ethylacetate and
ater. Both the extract and the various fractions were screened for
heir AChE and BuChE inhibitory activity.armacognosia 26 (2016) 433–437
Ethyl acetate extraction and precipitation studies
Powdered leaves of P. angolensis were bulk extracted with 100%
ethylacetate and the extract concentrated. Lipid constituent were
precipitated out by gradual addition of methanol. The precipi-
tates were ﬁltered and weighed. Both supernatants and precipitates
were then tested for cholinesterase inhibitory activity.
Phytochemical and cholinesterase analysis
The TLC of both the precipitates and the supernatant were
carried out using chloroform:hexane (7:3) as solvent system.
Some developed plates were sprayed with different phytochemical
screening reagents like vanillin/sulphuric acid, antimony trichlo-
ride, Dragendorff’s reagent and anisaldehyde spray reagents. The
other developed plates were subjected to TLC bioautographic
enzyme assay.
Cholinesterase inhibitory assay
The cholinesterase (both AChE and BuChE) inhibitory activities
of the crude extract, fractions, precipitate, supernatant and isolated
compounds were carried out using a 96 well micro-plate reader
according to the modiﬁed method of Ellman (Ellman et al., 1961;
Houghton et al., 2004; Eluﬁoye et al., 2013).
The reaction mixture contained 2000 ml  100 mM phosphate
buffer at pH 8.0, 100 ml  of test sample stock solution in methanol
at a ﬁnal concentration of 42.5 g/ml, 100 ml  of the enzyme, either
acetylcholinesterase (AChE) or butyrylcholinesterase (BuChE) at
a ﬁnal concentration of 0.003 /ml  and 0.001 /ml  respectively.
100 l of di-thio-nitrobenzoate (DTNB) (0.3 mM)  dissolved in
100 M phosphate buffer pH 7.0 containing 120 mM sodium bicar-
bonate. The assay mixture was pre-incubated on water bath at 37 ◦C
for 30 min  after proper mixing. The reaction was started by adding
of 100 l of acetyl thiocholine iodide (ATChI) or butyrylthiocholine
chloride (BTChCI) at a ﬁnal concentration of 0.5 mM.  Methanol and
eserin ((−) physiostigmine) were used as negative and positive
controls respectively. Change in absorbance at max 412 was  mea-
sured every 30 s over a period of 5 min  at ambient temperature. All
assays were carried out in triplicate and the percentage inhibition
calculated as:
Percentage inhibition = a − b
a
× 100
where a = A/min of control; b = A/min of test sample;
A = change in absorbance.
Active spots were also monitored by TLC bio-autographic assay
method according to Rhee et al. (2001). The samples were spotted
on pre-coated (G60 PF 254) TLC aluminium plate and developed
in appropriate solvent system. The developed plates were then air
dried and sprayed with 2.55 × 10−3 units/ml of the cholinesterase
enzyme until saturated. The plates were then incubated at 37 ◦C for
at least 20 min  before spraying with 0.5 mM of the substrate (ATChI
or BTChCI) and then DTNB. White spots on a yellow background
indicate positive result.
Isolation of bioactive components
The supernatant (120.36 g) was subjected to Vacuum
Liquid Chromatography (VLC) on silica gel using hexane,
dicholoromethane and methanol mixtures as the solvent sys-
tem. A total of 53 fractions were collected and bulked into six
based on their TLC proﬁle. The bulked fractions were subjected
to TLC autobiographic assay and fractions showing activity were
further puriﬁed by repeated VLC and PTLC leading to the isolation
of the compounds.
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Table 1
Anticholinesterase activity of extract and fractions of Pycnanthus angolensis.
Pycnanthus angolensis % Inhibition (AChE) % Inhibition (BuChE)
Methanol extract 43.96 ± 3.04 43.59 ± 1.77
Hexane fraction 23.94 ± 2.24 11.49 ± 1.97
Ethyl acetate fraction 65.66 ± 1.06 49.38 ± 1.66
Aqueous fraction 48.80 ± 1.15 42.17 ± 1.44
Precipitate 72.60 ± 3.34 ND
Supernatant 77.44 ± 1.18 NDT.O. Eluﬁoye et al. / Revista Brasileir
pectroscopic analysis
Spectroscopic analysis, both 1D and 2D NMR  were carried out.
tructure elucidation was done based on 1H and 13C NMR, COSY,
MQC, and HMBC spectra data.
esults and discussion
The precipitate and supernatant were spotted on pre-coated
ilica gel plates and subjected to preliminary phytochemical
creening by spraying with vanillin/H2SO4, Dragendoff reagent,
ntimony trichloride, and anisaldehyde spray reagent using the
ame solvent system (hexane:chloroform (3:7)). The TLC plate after
praying with vanillin/H2SO4 showed that supernatant gave better
olour reaction to the spraying reagent. The spots gave different
olours to the reagent and this could be indicative of the nature of
he constituents in the plants. Concentrated sulphuric acid is used
n the general detection of organic compounds (Harborne, 1973). It
s also useful in the detection of steroids, terpenes, lipids and essen-
ial oils (Pothier, 2000). Positive detection is indicated by a number
f colours, blue for linalol, red or violet for thymol, yellow–brown
or eugenol, etc. (Pothier, 2000). The above plate which showed dif-
erent colours with vanillin/H2SO4 indicates the presence of organic
ompounds such as terpenes, steroids or essential oils.
The TLC plate sprayed with Dragendoff reagent indicated the
resence of alkaloid in the precipitates of P. angolensis,  and C. jagus
ith positive reaction is indicated for alkaloids by orange-brown
ones against a yellow back ground (Pothier, 2000). The presence
f alkaloid may  be true because alkaloids have been found to have
ChE inhibitory activity (Houghton et al., 2004). Both eserin from
hysostigma venenosum and galanthamine from Crinum are alka-
oids which have been implicated as AChE inhibitors.
Antimony trichloride is used in the detection of cardiac gly-
osides and saponins (Pothier, 2000). Positive result is usually
ndicated by coloured zones for terpenoids and ﬂavonoids. The
lates showed some coloured (yellow) zones which could be ter-
enoids or ﬂavonoids in the precipitate and supernatant of P.
ngolensis.
Spraying with anisaldehyde was used for the detection of
erpenoids (usually purple, blue or red) and some other com-
ounds e.g. lignands, sugar and ﬂavonoids (Pothier, 2000). The plate
howed the presence of terpenoidal compounds in both super-
atant and precipitate.
Several compounds belonging to various classes have been pre-
iously reported in P. angolensis. These include ﬂavonoids (Mansoor
t al., 2011), fatty acids (Brill et al., 2004), terpenoid quinones
Wabo et al., 2007), lignands (Abrantes et al., 2008; Eric et al., 2010)
nd steroids (Connolly, 2006) thus supporting the validity of the
hytochemical screening.
Comparing the phytochemical analyses using the various spray
eagents and the TLC AChE and BuChE inhibitory activities, it could
e observed that supernatants gave more active spots. These spots
ould be steroids, terpenoids, or terpenes.
Both the quantitative and qualitative cholinesterase inhibitory
ssays of the precipitate and supernatant showed that the activity
as higher in the supernatant when compared with the precipitate
Table 1). It was also observed from the plate that BuChE appeared
ot to show as many active zones as AChE. Most of these com-
ounds are likely to be terpenoidal in nature because of their purple
olour in vanillin/H2SO4. Thus, the supernatant was subjected to
urther phytochemical analysis.TLC bioautographic AChE assay of fractions from the VLC as
ell as parallel spraying with vanillin/H2SO4 revealed the active
pots. The active sub-fractions were subjected to repeated VLC
eparately followed by PTLC to isolate compounds 1 and 2.Eserin 92.63 ± 3.66 89.30 ± 2.11
ND, not determined.
Spectroscopic analysis of the isolated compounds was done to con-
ﬁrm their structures.
Compound 1 was observed as oil with brownish yellow colour.
The 1H NMR  spectrum, (CDCl3, 300 Hz) showed signals at ı 6.4(s),
ı 5.4 (t), ı 4.1(d), ı 2.0(d), ı 1.4(m), ı 0.85(m), ı 0.87(m), ı 0.9(m), ı
1.70(s) and ı 1.60(s). The 13C NMR  (CDCl3, 300 Hz) data are: ı 59.63
(C-1), 123.30 (C-2), 140.50 (C-3), 40.08 (C-4), 26.93 (C-5), 37.51 (C-
6), 33.90 (C-7), 37.64 (C-8), 25.35 (C-9), 39.95 (C-10), 33.01 (C-11),
39.58 (C-12), 25.00 (C-13), 37.50 (C-14), 28.19 (C-15), 29.91 (C-16),
36.88 (C-17), 135.50 (C-18), 123.48 (C-19), 24.68 (C-20), 16.23 (C-
21), 16.38 (C-22), 19.96 (C-23), 22.83 (C-24), 22.92 (C-25), 19.93
(C-26).
The signal at 5.4(t) represents the oleﬁnic protons assigned to
the protons on C-2 and C-19. The signal at ı 4.1(d) represents an
alcohol proton and is assigned to the proton residing on C-1. The
multiplet signals at ı 1.40 to ı 1.35 represent the methylene pro-
tons on C-7, C-11 and C-15. The multiplets at ı 1.30 to ı 1.00 were
assigned to protons on C-6, C-8, C-9, C-10, C-12, C-13, C-14, C-16,
and C-17. The signal at ı 1.60(s) was  assigned to the methyl pro-
tons on C-22 and C-26 while the signal at ı 1.70 was assigned to
the OH group. The remaining signals at ı 0.85(m), ı 0.87(m) and ı
0.9(m) were assigned to the methyl protons on C-21, C-23, C-24 and
C-25.
The 13C spectrum showed that there were 6CH3, 13CH2, 5CH
and 2C. Thus, compound 1 appears to be a C-26 carbon compound.
Diagnostic are the oxygenated terminal methylene carbon resonat-
ing at ı 59.39 (C-1), the methine carbons resonating at ıc 123.39 and
ıc 123.48 (C-2 and C-19), respectively, and the quaternary carbons
C-3 and C-19 resonating at ıc 140.50 and ıc 135.50 respectively.
The tertiary methyl groups (C-22 and C-26) on C-3 and C-18 res-
onated at ıc 16.38 and ıc 19.93, respectively; the secondary methyl
groups (C-23, C-24 and C-25) resonated at ıc 19.96, ıc 22.83 and
ıc 22.92 while the terminal methyl group (C-21) resonated at ıc
16.23.
On analyzing the spectra of compound 1, it appears to be an
extension of phytol by additional double bound and methyl groups.
While phytol is C-20 (Arigoni et al., 1999), compound 1 is a C-26
compound with additional CH3 at C-22, CH2 at C-16, C-17 and C-20,
CH at C-19 and Cq at C-18. This compound (2E, 18E)-3,7,11,15,18-
pentamethylhenicosa-2,18-dien-1-ol, named eluptol, appears new
and it is also being reported for cholinesterase inhibitory activity
for the ﬁrst time.
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Spectra data for compound 2 are as follows:
1H NMR  (CDCl3, 300 Hz): ı 6.6(s), ı 6.4(s), ı 6.0(t), ı 5.1(m), ı
.2(t), ı 3.1(d), ı 2.6(dd), ı 2.2(m), ı 2.0(m), ı 1.6(m), and ı 1.2(m).
3C NMR  (CDCl3, 300 Hz) ı 132.30 (C-1),124.73 (C-2), 132.42(C-3),
34.77 (C-4), 139.94 (C-5), 123.74 (C-6), 145.69 (C-7), 118.32 (C-8),
73.52 (C-9), 68.33 (C-10), 28.11 (C-11), 26.56 (C-12), 28.38 (C-13),
9.29 (C-14), 34.76 (C-15), 29.91 (C-16), 29.58 (C-17), 27.76 (C-18),
9.26 (C-19), 25.85 (C-20), 39.79 (C-21), 146.10 (C-22), 133.33 (C-
3), 130.91 (C-24), 148.68 (C-25), 188.18 (C-26), 16.11 (C-27), 17.88
C-28), 16.15 (C-29), 16.28 (C-30).
The 13C spectrum of compound 2 showed that there were 4CH3,
1CH2, 7CH and 8C. Thus, compound 2 appears to be a C-30 com-
ound. Particular are the carbonyl carbons C-9 and C-26 which
esonated at ıc 173.52 and ıc 188.18, respectively. Also diagnostic
s the oxygenated methylene carbon at C-10 which acts as a bridge
etween the two aromatic ring systems and resonated at ıc 68.33.
iagnostic also is the methine carbons C-7 and C-8 resonating at ıc
45.69 and ıc 118.32, respectively which are in HMBC correlating
ith the carbonyl at C-9. The quaternary carbons C-25 (ıc 148.68)
as differentiated from that at C-24 (ıc 130.91) due to the hydroxyl
roup on C-25 which made it absorb at a higher value. The tertiary
ethyl groups C-27, C-29 and C-30 resonated at ıc 16.11, ıc 16.15
nd ıc 16.28 while the secondary methyl carbon C-28 resonated at
c 17.88.
The proton NMR  signal at ı 6.6 (s) represents the methyene pro-
on residing on C-23 resonating at ı 133.33 in the HMQC while that
t ı 6.4 (s) resides on C-3 at ı 132.42. The triplet at ı 6.0 was shown
o reside on the carbon at ı 145.69 which was assigned as C-7. The
ultiplet at ı 5.1 showed correlation with the carbons at ı 124.73
C-2),  123.74 (C-6), and ı 118.32 (C-8) in the HMQC spectra. The
ignal at ı 4.2 (t), showed correlation with the diagnostic OCH2 car-
on at ı 68.33 and is assigned to C-10 while the signal at ı 3.1 (d)
orrelated with the carbon at ı 27.76 assigned to C-18. The mul-
iplet at ı 2.2 to ı 2.0 correlated with carbon signals at ı 26.56, ı
4.76, ı 29.58, and ı 39.79 and were assigned to carbons C-12, C-15,
-17 and C-21 while the multiplet at ı 1.6 to ı 1.2 were assigned
o the methyl groups at C-27, C-28, C-29 and C-30. In the HMBC,
he diagnostic CH2 at C-10 showed correlation with the CH2 signal
t ı 28.11 which was assigned to C-11. Also the CH2 at ı 39.79 (C-
1) is coupled to the quaternary carbon at ı 146.10 (C-22) while
he carbonyl carbon at ı 188.18 (C-26) is coupled to the carbon
esonating at ı 133.33 (C-23). The HMBC spectra also showed that
he CH at ı 145.69 (C-7) coupled with the quaternary carbon at ı
73.52 (C-9).
MBC correlations of compound 2
When compared with literature (Renmin et al., 2004;
enkateswara et al., 2011), it was observed that compound 2 is
 cinnamic acid derivative. There are, however, differences at C-
 and C-5 of the isolated compound and cinnamic acid because
f the 4,5-dimethyl substitution on PA-3 which made these car-
ons absorb at slightly higher ı values (ı 134.77 and ı 139.94),
espectively. Derivatives of cinnamic acid in the literature are
ostly 2,3-dimethoxy or 2,3-dihydroxy unlike compound 2 which
s a 2,3-dimethyl derivative. Also, the group attached to the cin-
amic acid through the ester linkage has never been reportedarmacognosia 26 (2016) 433–437
as such in the literature. Thus compound 2,[12-(4-hydroxy-3-
methyl-oxo-cyclopenta-1,3-dien-1yl)-11-methyl-dodecyl] (E)-3-
(3,4-dimethylphenyl)prop-2-enoate, named omifoate A appears to
be new as well and it is being reported as cholinesterase inhibitor
for the ﬁrst time.
In conclusion, extracts of the leaves of P. angolensis inhibited
cholinesterase enzymes and two  new compounds with signiﬁcant
cholinesterase inhibitory activity were isolated from the super-
natant of the most active ethyl acetate fraction.
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